glp 1 eczema A Closer Look at the Dermatological Profile of GLP-1 Agonists Beyond Weight Loss: Clinical Perspectives

In recent years, the drugs have transitioned from being solely for type 2 diabetes treatment to increasing use as weight loss drugs, with Novo Nordisks Wegovy and Eli Lillys Zepbound being developed specifically for that purpose

Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dual GIP/GLP-1 agonist, meaning it acts on two receptors instead of one

The FTC has studied this question multiple times and reached mixed conclusions

Research shows that about 54% of people discontinue within a year for various reasons, like cost or side effects

However, if you experience nausea in the morning from your GLP-1 medication, an evening dose of fiber might be more tolerable

A few small clinical studies and observational reports indicate that individuals treated with GLP1 RAs may report reduced alcohol cravings and lower consumption levels